These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32337707)

  • 1. Creating E-Labeling Platforms: An Industry Vision.
    Roberts K; Thakkar R; Autor D; Bisordi F; Fitton H; Garner C; Garvin M; Honig P; Hukkelhoven M; Kowalski R; Milligan S; O'Dowd L; Olmstead S; Reilly E; Robertson AS; Rohrer M; Stewart J; Taisey M; Van Baelen K; Wegner M
    Clin Pharmacol Ther; 2020 Oct; 108(4):716-718. PubMed ID: 32337707
    [No Abstract]   [Full Text] [Related]  

  • 2. VA pursues bar-code quality.
    Young D
    Am J Health Syst Pharm; 2004 Jul; 61(13):1312, 1314. PubMed ID: 15287219
    [No Abstract]   [Full Text] [Related]  

  • 3. Information Blocking: Is It Occurring and What Policy Strategies Can Address It?
    Adler-Milstein J; Pfeifer E
    Milbank Q; 2017 Mar; 95(1):117-135. PubMed ID: 28266065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA to develop rules for mandatory bar-code labels.
    Thompson CA
    Am J Health Syst Pharm; 2002 Jan; 59(2):107, 112. PubMed ID: 11826558
    [No Abstract]   [Full Text] [Related]  

  • 5. Implementing the Cures Act - Bringing Consumer Computing to Health Care.
    Rucker DW
    N Engl J Med; 2020 May; 382(19):1779-1781. PubMed ID: 32160450
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data.
    Strech D; Littmann J
    Trials; 2012 Jul; 13():100. PubMed ID: 22747684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health information on alcoholic beverage containers: has the alcohol industry's pledge in England to improve labelling been met?
    Petticrew M; Douglas N; Knai C; Durand MA; Eastmure E; Mays N
    Addiction; 2016 Jan; 111(1):51-5. PubMed ID: 26467551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion.
    Surprenant JA
    Fordham Law Rev; 2008 Oct; 77(1):327-63. PubMed ID: 18982554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indonesia: Warnings need stronger enforcement.
    Soerojo W
    Tob Control; 2015 Mar; 24(2):107-8. PubMed ID: 25853153
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA preemption of drug and device labeling: who should decide what goes on a drug label?
    Valoir T; Ghosh S
    Health Matrix Clevel; 2011; 21(2):555-98. PubMed ID: 22145525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Would a cigarette by any other name taste as good in China?
    Wang L; Jin Y; Berman M; Ferketich AK
    Tob Control; 2016 Nov; 25(6):638-639. PubMed ID: 26743011
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-31. PubMed ID: 20217914
    [No Abstract]   [Full Text] [Related]  

  • 13. Drafting warnings for medical products: practical considerations for minimizing litigation.
    Dunne KJ; Patterson KD; Baroumand CR
    Healthspan; 1993 Sep; 10(8):11-20. PubMed ID: 10129147
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction: Comparative health law and policy: what, if anything, can we learn from other countries?
    Hoffmann D
    J Law Med Ethics; 2009; 37(4):790-1. PubMed ID: 20122124
    [No Abstract]   [Full Text] [Related]  

  • 16. Industry relations.
    Shortell CK
    J Vasc Surg; 2011 Sep; 54(3 Suppl):1S-2S. PubMed ID: 21872106
    [No Abstract]   [Full Text] [Related]  

  • 17. In the interest of privacy. Deborah Peel has some blunt words on the increased push for data-mining.
    Conn J
    Mod Healthc; 2007 May; 37(20):30-1. PubMed ID: 17542310
    [No Abstract]   [Full Text] [Related]  

  • 18. Restrictions on interactions between doctors and industry could ultimately hurt patients.
    Kimmelstiel C
    J Vasc Surg; 2011 Sep; 54(3 Suppl):12S-4S. PubMed ID: 21872108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Symbols in Labeling. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2016 Jun; 81(115):38911-31. PubMed ID: 27311137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data Citizenship under the 21st Century Cures Act.
    Mandl KD; Kohane IS
    N Engl J Med; 2020 May; 382(19):1781-1783. PubMed ID: 32160449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.